(C) Vancouver General Hospital.
This monograph may not be reproduced without permission.
For further information, please contact a Pharmacist.

NAME OF DRUG
acetylcysteine


CLASSIFICATION

Antidote

ALTERNATE NAME

MUCOMYST

INDICATIONS

RECONSTITUTION AND STABILITY

COMPATIBILITY

ROUTES OF ADMINISTRATION

VH & HSC ADMINISTRATION POLICY

A - Not to be administered by the direct IV route

DOSAGE

Initial dose of 150 mg/kg over 1 hour, followed by 50 mg/kg over 4 hours and 100 mg/kg over the next 16 hours.

Amount of a 20% (200mg/mL) acetylcysteine solution required (mLs)

Body Weight (kg) Initial infusion: in 200mL D5W over 1 hour 2nd infusion: in 500mL D5W over 4 hours 3rd infusion: in 1000mL D5W over 16 hours
40 - 50 37.5 12.5 25.0
50 - 60 45.0 15.0 30.0
60 - 70 52.5 17.5 35.0
70 - 80 60.0 20.0 40.0
80 - 90 67.5 22.5 45.0
90 - 100 75.0 25.0 50.0
100 - 110 82.5 27.5 55.0

Alternate method: Initial dose of 140mg/kg over 1 hour, followed by 70mg/kg over 1 hour q4h x 12 doses

POTENTIAL HAZARDS OF PARENTERAL ADMINISTRATION

IMPORTANT IMPLICATIONS

Plasma level umol/L (mcg/mL) Hours post-ingestion
993 (150) 4
464 (70) 8
132 (20) 15
26 (4) 24

Revised March 2005